Introduction RAS proteins (KRAS, NRAS, HRAS) are among the most frequently mutated oncogenic drivers across human cancers, particularly pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), and non-small cell lung cancer (NSCLC).1 2 RAS proteins function as small GTPases that cycle between an inactive GDP-bound state (RAS(OFF)) and an active GTP-bound state (RAS(ON)), with the ON state signaling through RAF kinases and downstream MAPK (RAS-RAF-MEK-ERK) and PI3K pathways.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Clément
Contact Clément, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack